MAT2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.833700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.966780E-01
Normal-vs-Stage2
8.980300E-02
Normal-vs-Stage3
3.705900E-02
Normal-vs-Stage4
5.133800E-01
Stage1-vs-Stage2
8.733800E-01
Stage1-vs-Stage3
1.769030E-01
Stage1-vs-Stage4
6.428000E-01
Stage2-vs-Stage3
8.068300E-02
Stage2-vs-Stage4
5.676200E-01
Stage3-vs-Stage4
1.660000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.817600E-02
Normal-vs-AfricanAmerican
1.670570E-01
Normal-vs-Asian
3.160000E-01
Caucasian-vs-AfricanAmerican
9.965200E-01
Caucasian-vs-Asian
6.210200E-01
AfricanAmerican-vs-Asian
8.136800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.796300E-02
Normal-vs-Female
5.907900E-02
Male-vs-Female
7.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.422010E-01
Normal-vs-Age(41-60Yrs)
2.110200E-01
Normal-vs-Age(61-80Yrs)
4.354400E-02
Normal-vs-Age(81-100Yrs)
3.106400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.976760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.616600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.027600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.162700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.952620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.971000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.994300E-02
Normal-vs-Daily Drinker
1.024390E-01
Normal-vs-Weekly Drinker
3.524100E-02
Normal-vs-Occasional Drinker
2.532400E-01
Normal-vs-Social Drinker
2.836000E-02
Non Drinker-vs-Daily Drinker
5.756200E-01
Non Drinker-vs-Weekly Drinker
1.480210E-01
Non Drinker-vs-Occasional Drinker
6.311400E-01
Non Drinker-vs-Social Drinker
6.212600E-01
Daily Drinker-vs-Weekly Drinker
4.274800E-01
Daily Drinker-vs-Occasional Drinker
3.961800E-01
Daily Drinker-vs-Social Drinker
9.359400E-01
Weekly Drinker-vs-Occasional Drinker
1.307030E-01
Weekly Drinker-vs-Social Drinker
3.127600E-01
Occasional Drinker-vs-Social Drinker
3.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.542400E-02
Normal-vs-Grade 2
6.360800E-03
Normal-vs-Grade 3
2.497600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.702940E-03
Grade 1-vs-Grade 3
1.424690E-03
Grade 1-vs-Grade 4
8.542400E-02
Grade 2-vs-Grade 3
7.685800E-01
Grade 2-vs-Grade 4
6.360800E-03
Grade 3-vs-Grade 4
2.497600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.942000E-02
Normal-vs-NonDiabetic
5.774100E-02
Diabetic-vs-NonDiabetic
6.017000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.763500E-02
Normal-vs-NoPancreatitis
6.138100E-02
Pancreatitis-vs-NoPancreatitis
9.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.829800E-02
Normal-vs-N1
9.043700E-02
N0-vs-N1
4.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.184000E-01
Normal-vs-TP53-NonMutant
1.547590E-01
TP53-Mutant-vs-TP53-NonMutant
3.049600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
